Global Patent Index - EP 2906201 A4

EP 2906201 A4 20161019 - SOLID DOSAGE FORM

Title (en)

SOLID DOSAGE FORM

Title (de)

FESTSTOFFDOSIERUNGSFORM

Title (fr)

FORME DE DOSAGE SOLIDE

Publication

EP 2906201 A4 20161019 (EN)

Application

EP 13845400 A 20131011

Priority

  • AU 2012238330 A 20121011
  • AU 2013200682 A 20130208
  • AU 2013200684 A 20130208
  • IB 2013002594 W 20131011

Abstract (en)

[origin: WO2014057351A1] There is provided a solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form comprises at least one biologically active material, and at least one matrix forming agent, wherein the dosage form substantially dissolves in the oral cavity. A method of producing the same and a kit comprising the same are also provided.

IPC 8 full level

A61K 9/26 (2006.01); A61K 9/20 (2006.01)

CPC (source: CN EP IL)

A61K 9/0056 (2013.01 - CN EP); A61K 9/2059 (2013.01 - CN); A61K 9/2095 (2013.01 - CN EP); A61K 31/135 (2013.01 - EP IL); A61K 31/137 (2013.01 - EP IL); A61K 31/4045 (2013.01 - CN); A61K 31/4468 (2013.01 - CN); A61K 31/485 (2013.01 - CN EP); A61K 31/519 (2013.01 - EP IL); A61K 31/5517 (2013.01 - CN); A61K 38/063 (2013.01 - CN)

Citation (search report)

  • [XY] US 2010240724 A1 20100923 - CHANG SEOK HOON [KR], et al
  • [IY] WO 0205820 A1 20020124 - LAVIPHARM LAB INC [US]
  • [Y] CN 102438596 A 20120502 - NAL PHARMACEUTICALS LTD
  • [I] US 2011009834 A1 20110113 - ASMUSSEN BODO [DE], et al
  • [I] WO 2011117313 A1 20110929 - BIOALLIANCE PHARMA [FR], et al
  • [I] US 2009246257 A1 20091001 - MODI PANKAJ [CA]
  • [Y] FR 2967066 A1 20120511 - ETHYPHARM SA [FR]
  • [Y] US 7407669 B2 20080805 - LEUNG SAU-HUNG SPENCE [US], et al
  • [IY] TOURDOT S ET AL: "The use of a mucoadhesive microparticulate delivery system enables allergen dose reduction with equivalent efficacy in sublingual immunotherapy", ALLERGY, WILEY-BLACKWELL PUBLISHING LTD, UNITED KINGDOM, vol. 66, no. Suppl. 94, 1 June 2011 (2011-06-01), pages 135, XP009189546, ISSN: 0105-4538
  • [Y] DIXIT R P ET AL: "Oral strip technology: Overview and future potential", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 139, no. 2, 15 October 2009 (2009-10-15), pages 94 - 107, XP026601268, ISSN: 0168-3659, [retrieved on 20090624], DOI: 10.1016/J.JCONREL.2009.06.014
  • [A] DEVECI S ET AL: "SUBLINGUAL SILDENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION: FASTER ONSET OF ACTION WITH LESS DOSE", INTERNATIONAL JOURNAL OF UROLOGY, CHURCHILL LIVINGSTONE, TOKYO, JP, vol. 11, no. 11, 1 January 2004 (2004-01-01), pages 989 - 992, XP008068622, ISSN: 0919-8172, DOI: 10.1111/J.1442-2042.2004.00933.X
  • [A] SANFORD M: "Vardenafil orodispersible tablet", DRUGS, ADIS INTERNATIONAL LTD, NZ, vol. 72, no. 1, 1 January 2012 (2012-01-01), pages 87 - 98, XP009189559, ISSN: 0012-6667, DOI: 10.2165/11208270-000000000-00000
  • [Y] JOSHUA S BOATENG ET AL: "Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces", INTERNATIONAL JOURNAL OF PHARMACEUTICS, ELSEVIER BV, NL, vol. 389, no. 1, 9 January 2010 (2010-01-09), pages 24 - 31, XP028308317, ISSN: 0378-5173, [retrieved on 20100118], DOI: 10.1016/J.IJPHARM.2010.01.008
  • [Y] SUBASHVIJAYAKUMAR ET AL: "OVERVIEWONFASTDISSOLVINGFILMS", 3 May 2010 (2010-05-03), XP055291076, Retrieved from the Internet <URL:http://www.ijppsjournal.com/Vol2Suppl3/665.pdf> [retrieved on 20160725]
  • [Y] CHONG CHUI ET AL: "Development of a Sublingual/Oral Formulation of Ketamine for Use in Neuropathic Pain Preliminary Findings from a Three-Way Randomized, Crossover Study", CLINICAL DRUG INVESTIGATION, vol. 29, no. 5, 2009, pages 317 - 324, XP009191103, ISSN: 1173-2563

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2014057351 A1 20140417; CA 2886573 A1 20140417; CA 2886573 C 20190402; CN 104812378 A 20150729; CN 104812378 B 20171201; CN 107669649 A 20180209; EP 2906201 A1 20150819; EP 2906201 A4 20161019; HK 1208353 A1 20160304; IL 238104 A0 20150531; IL 238104 B 20200331; IL 273076 A 20200430; JP 2015533155 A 20151119; KR 20150063567 A 20150609; MY 191875 A 20220718; NZ 706302 A 20170728; SG 11201502425W A 20150528

DOCDB simple family (application)

IB 2013002594 W 20131011; CA 2886573 A 20131011; CN 201380060281 A 20131011; CN 201711156600 A 20131011; EP 13845400 A 20131011; HK 15108989 A 20150915; IL 23810415 A 20150401; IL 27307620 A 20200304; JP 2015536236 A 20131011; KR 20157012031 A 20131011; MY PI2015000938 A 20131011; NZ 70630213 A 20131011; SG 11201502425W A 20131011